Co-Authors
This is a "connection" page, showing publications co-authored by Giuliano Rizzardini and Paolo Bonfanti.
Connection Strength
0.220
-
HIV Clinical Pathway: A New Approach to Combine Guidelines and Sustainability of Anti-Retroviral Treatment in Italy. PLoS One. 2016; 11(12):e0168399.
Score: 0.174
-
Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients. Ther Clin Risk Manag. 2017; 13:787-797.
Score: 0.045